Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial

BACKGROUND: Following radical nephro-ureterectomy for urothelial carcinoma of the upper urinary tract (UUT), the reported bladder recurrence rate of urothelial carcinoma is 22–47%. A single intravesical instillation of chemotherapy within 10 days following nephro-ureterectomy has the potential to de...

Descripción completa

Detalles Bibliográficos
Autores principales: van Doeveren, T., van Leeuwen, P.J., Aben, K.K.H., van der Aa, M., Barendrecht, M., Boevé, E.R., Cornel, E.B., van der Heijden, A.G., Hendricksen, K., Hirdes, W., Kooistra, A., Kroon, B., Leliveld, A.M., Meijer, R.P., van Melick, H., Merks, B., de Reijke, T.M., de Vries, P., Wymenga, L.F.A., Wijsman, B., Boormans, J.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898538/
https://www.ncbi.nlm.nih.gov/pubmed/29696234
http://dx.doi.org/10.1016/j.conctc.2018.01.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898538/
https://www.ncbi.nlm.nih.gov/pubmed/29696234
http://dx.doi.org/10.1016/j.conctc.2018.01.007

Ejemplares similares